Pierre Geborek
41 – 60 of 135
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.
(
- Contribution to journal › Article
-
Mark
Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Individualized outcome measures of daily activities are sensitive tools for evaluating hand surgery in rheumatic diseases.
2012) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
A survey of spinal collateral actions of feline ventral spinocerebellar tract neurons.
2012) In European Journal of Neuroscience(
- Contribution to journal › Article
- 2011
-
Mark
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
(
- Contribution to journal › Article
-
Mark
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
(
- Contribution to journal › Article
-
Mark
Prevalence of spondyloarthritis and its subtypes in southern Sweden
(
- Contribution to journal › Article
-
Mark
The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trials.
(
- Contribution to journal › Article
-
Mark
Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment.
(
- Contribution to journal › Article
-
Mark
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases
(
- Contribution to journal › Scientific review
-
Mark
Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
(
- Contribution to journal › Article
-
Mark
Ten years with biologics: to whom do data on effectiveness and safety apply?
(
- Contribution to journal › Article
- 2010
-
Mark
Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression.
(
- Contribution to journal › Article
-
Mark
Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Utility-based outcomes made easy: The number needed per QALY gained (NNQ). Observational cohort study from Southern Sweden of TNF blockade in inflammatory arthritis.
(
- Contribution to journal › Article